View printer-friendly version << Back
MEDNAX Announces the Acquisition of Ft. Lauderdale, FL Neonatal

FORT LAUDERDALE, Fla., Jun 03, 2010 (BUSINESS WIRE) --MEDNAX, Inc., (NYSE: MD) today announced the acquisition of a neonatal physician group based in Ft. Lauderdale, Florida.

The practice, Lalit K. Shah, M.D., P.A., consists of two physicians who staff the Level II neonatal intensive care unit (NICU) at Holy Cross Hospital in Ft. Lauderdale, FL. Annual NICU patient volume at Holy Cross Hospital exceeds 1,500 days.

The physicians will practice as part of MEDNAX's Pediatrix Medical Group, a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal medicine and pediatric cardiology physicians, as well as other pediatric subspecialists.

"Our practice has provided care for premature babies in South Florida for more than two decades, and we look forward to now having the ability to collaborate with Pediatrix's team of specialists, including those in the local area, to ensure that the entire community continues to receive the highest level of quality neonatal care," said Jwalanaiah Bellur, M.D., who will serve as Pediatrix's medical director for the practice. "As part of Pediatrix we will be joining a group of physicians who share our own commitment to continuously improving patient outcomes through ongoing education, research and the use of evidence-based medicine to apply the best clinical practices to the care we provide to each of our neonatal patients."

MEDNAX paid cash for the practice, and the transaction is expected to be immediately accretive to its earnings. No additional terms of the transaction were disclosed.

With this acquisition, seven physician group practices have become part of Pediatrix Medical Group in 2010.


MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 275 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 550 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,450 physicians in 33 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts,that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that couldcause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX's most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled "Risk Factors", as well MEDNAX's current reports on Form 8-K,filed with the Securities and Exchange Commission.


Bob Kneeley, Director, Investor Relations, 954-384-0175 x 5300